purpose evaluate applicability carbon ion beams treatment choroidal melanoma regard normal tissue morbidity local tumor control methods materials january NUMBER february NUMBER NUMBER patients locally advanced unfavorably located choroidal melanoma enrolled phase clinical trial radiotherapy national institute radiologic sciences primary endpoint study normal tissue morbidity secondary endpoints local tumor control patient survival NUMBER subjects enrolled NUMBER followed NUMBER months analyzed results patients NUMBER developed neovascular glaucoma underwent enucleation eye pain elevated intraocular pressure incidence neovascular glaucoma dependent tumor size site patients died analysis distant metastasis concurrent disease patient developed marginal recurrence controlled locally patients developed distant metastasis liver lung overall survival survival local control rates NUMBER NUMBER NUMBER respectively apparent relationship observed tumor control normal tissue morbidity dose range applied conclusion radiotherapy applied choroidal melanoma acceptable morbidity sufficient antitumor effect tumors unfavorable size site carbon ion year disease free dose response carbon ion ii